Y.-M. Hung et al. / Tetrahedron: Asymmetry 26 (2015) 1369–1374
1373
2H), 7.46 (t, J = 7.6 Hz, 1H), 7.52 ppm (d, J = 8.0 Hz, 2H). 13C NMR
(100 MHz, CDCl3): d = 12.1, 27.3, 43.7, 49.4, 55.6, 74.8, 122.8,
125.7, 127.5, 127.9, 128.1, 129.2, 130.3, 130.7, 130.8,
133.5, 138.4, 140.5, 140.6, 203.5 ppm. HRMS (ESI) calcd for
t(minor) = 14.5 min, t(major) = 29.6 min; 96% ee. [
(c 1.0, CH2Cl2).
a
]
22.9 = ꢀ57.0
D
4.1.1.13.
(2S,3S)-2-((R)-2-Nitro-1-phenylethyl)-1-phenyl-3-p-
1H NMR (400 MHz, CDCl3):
C25H24BrNNaO3 [M+Na]: 488.0832, found 488.0835. HPLC analysis:
tolylpentan-1-one 4m3o
.
Chiralcel AD-H, 2-propanol/hexane (5:95), 1.0 mL/min, UV
d = 0.56 (t, J = 7.2 Hz, 3H), 1.37–1.49 (m, 2H), 2.36 (s, 3H), 2.88
(td, J = 3.6 Hz, 10.8 Hz, 10.8 Hz, 1H), 3.55–3.60 (m, 1H), 4.07 (dd,
J = 4.4 Hz, J = 10.4 Hz, 1H), 4.90 (dd, J = 3.6 Hz, J = 13.6 Hz, 1H),
5.01–5.07 (m, 1H), 6.94 (d, 7.6 Hz, 2H), 7.06–7.18 (m, 3H), 7.20–
7.23 (m, 3H), 7.24–7.40 (m, 3H), 7.40–7.45 ppm (m, 3H). 13C
NMR (100 MHz, CDCl3): d = 12.1, 21.1, 27.3, 43.9, 49.1, 56.2, 75.1,
127.3, 127.6, 127.8, 128.1, 128.3, 128.8, 129.8, 133.1, 136.9,
137.7, 138.2, 138.7, 204.2 ppm. HPLC analysis: Chiralcel AD-H,
2-propanol/hexane (5:95), 1.0 mL/min, UV 254 nm; t(minor)
22.9
254 nm; t(minor) = 9.3 min, t(major) = 22.0 min; 96% ee. [
a
]
D
=
ꢀ21.4 (c 1.0, CH2Cl2).
4.1.1.9. (2S,3S)-2-((R)-1-(3-Methoxyphenyl)-2-nitroethyl)-1,3-
diphenyl-pentan-1-one 4i3p 1H NMR (400 MHz, CDCl3):
.
d = 0.57 (t, J = 7.6 Hz, 3H), 1.41–1.55 (m, 2H), 2.93 (td, J = 3.2 Hz,
10.4 Hz, 10.4 Hz, 1H), 3.57 (s, 3H), 4.10 (dd, J1 = 4.8 Hz, J2 = 10 Hz,
1H), 4.89 (dd, J1 = 4.0 Hz, J2 = 13.6 Hz, 1H), 4.95–5.01 (m, 1H),
6.45 (s, 1H), 6.53 (d, J = 7.6 Hz, 1H), 6.61 (d, J = 8.0 Hz, 1H), 7.01
(t, J = 8.0 Hz, 1H), 7.23–7.30 (m, 5H), 7.36–7.45 (m, 3H), 7.50 ppm
(d, J = 7.6 Hz, 2H). 13C NMR (100 MHz, CDCl3): d = 11.9, 26.6, 43.9,
49.1, 54.6, 55.4, 75.1, 112.7, 112.9, 119.3, 127.0, 127.8, 128.1,
129.6, 132.9, 138.3, 139.5, 140.7, 159.5, 203.6 ppm. HRMS (ESI)
calcd for C26H27NNaO4 [M+Na]: 440.1832, found 440.1839. HPLC
analysis: Chiralcel AD-H, 2-propanol/hexane (5:95), 1.0 mL/min,
UV 254 nm; t(minor) = 12.1 min, t(major) = 23.3 min; 97% ee.
= 9.00 min, t(major) = 14.6 min; 96% ee. [
a]
D
22.9 = ꢀ46.8 (c 1.0,
CH2Cl2).
4.1.1.14.
(2S,3S)-3-(4-Chlorophenyl)-2-((R)-2-nitro-1-phenyl-
1H NMR (400 MHz,
ethyl)-1-phenylpentan-1-one 4n3o,p
.
CDCl3): d = 0.56 (t, J = 7.2 Hz, 3H), 1.36–1.43 (m, 1H), 1.47–1.54
(m, 1H), 2.90 (td, J = 3.2 Hz, 11.6 Hz, 11.6 Hz, 1H), 3.56–3.61 (m,
1H), 4.06 (dd, J = 5.2 Hz, J = 9.6 Hz, 1H), 4.85 (dd, J = 3.6 Hz,
J = 13.6 Hz, 1H), 4.93–4.99 (m, 1H), 6.94–6.96 (m, 2H), 7.11–7.16
(m, 5H), 7.23–7.27 (m, 3H), 7.34 (d, J = 8.4 Hz, 2H), 7.45 ppm (d,
J = 8.4 Hz, 2H). 13C NMR (100 MHz, CDCl3): d = 12.0, 26.6, 44.1,
48.7, 55.7, 75.4, 127.3, 127.7, 128.1, 128.4, 128.9, 129.2, 129.3,
132.9, 133.3, 137.8, 138.4, 139.5, 203.5 ppm. HPLC analysis: Chiral-
cel AD-H, 2-propanol/hexane (5:95), 1.0 mL/min, UV 254 nm; t
[
a]
D
22.8 = ꢀ38.8 (c 1.0, CH2Cl2).
4.1.1.10.
phenylpropyl)pentan-1-one 4j.
(2S,3S)-4-Methyl-3-(nitromethyl)-1-phenyl-2-((S)-1-
1H NMR (400 MHz, CDCl3):
d = 0.56 (t, J = 7.6 Hz, 3H), 0.63 (d, J = 6.8 Hz, 3H), 0.70 (d,
J = 7.2 Hz, 3H), 1.43–1.54 (m, 2H), 2.18–2.24 (m, 1H), 2.85 (td,
J = 4.0 Hz, 10.8 Hz, 10.8 Hz), 4.13 (dd, J = 2.4 Hz, J = 10.4 Hz), 4.48
(dd, J = 10.4 Hz, J = 14.4 Hz), 4.99 (dd, J = 2.4 Hz, J = 14.0 Hz),
7.22–7.30 (m, 2H), 7.35–7.39 (m, 2H), 7.51–7.50 (m, 2H), 7.60–
7.64 (m, 1H), 8.04 ppm (d, J = 7.6 Hz, 2H). 13C NMR (100 MHz,
CDCl3): d = 12.4, 19.3, 19.9, 27.9, 29.7, 44.0, 48.6, 50.4, 75.6,
127.2, 128.2, 128.3, 128.8, 128.9, 133.6, 138.7, 141.3, 204.4 ppm.
HRMS (ESI) calcd for C22H27NNaO3 [M+Na]: 376.1883, found
376.1883. HPLC analysis: Chiralcel AD-H, 2-propanol/hexane
(5:95), 0.5 mL/min, UV 254 nm; t(minor) = 14.1 min, t(major)
(minor) = 12.7 min, t(major) = 27.0 min; 93% ee.
(c 1.0, CH2Cl2).
[a
]
23.0 = ꢀ49.2
D
4.1.1.15.
(2S,3S)-3-(3-Chlorophenyl)-2-((R)-2-nitro-1-phenyl-
ethyl)-1-phenylpentan-1-one 4o3o
.
1H NMR (400 MHz,
CDCl3): d = 0.56 (t, J = 7.2 Hz, 3H), 1.38–1.52 (m, 2H), 2.88 (td,
J = 3.2 Hz, 11.2 Hz, 11.2 Hz, 1H), 3.59–3.64 (m, 1H), 4.07 (dd,
J = 5.2 Hz, J = 9.6 Hz, 1H), 4.83 (dd, J = 3.6 Hz, J = 13.2 Hz, 1H),
4.92–4.98 (m, 1H), 6.95–6.98 (m, 2H), 7.07–7.16 (m, 4H), 7.18
(s, 1H), 7.25–7.30 (m, 4H), 7.42–7.47 ppm (m, 3H). 13C NMR
(100 MHz, CDCl3): d = 12.1, 26.4, 44.2, 49.0, 55.7, 75.6, 126.6,
127.4, 127.7, 127.8, 128.1, 128.9, 130.3, 133.4, 134.9, 137.8,
138.4, 143.2, 203.3 ppm. HPLC analysis: Chiralcel AD-H, 2-propa-
nol/hexane (5:95), 1.0 mL/min, UV 254 nm; t(minor) = 10.6 min,
= 17.0 min; 97% ee. [
a]
25.8 = ꢀ138.7 (c 1.0, CH2Cl2).
D
4.1.1.11.
propyl)hexan-1-one 4k.
(2S,3S)-3-(Nitromethyl)-1-phenyl-2-((S)-1-phenyl-
1H NMR (400 MHz, CDCl3):
d = 0.56–0.62 (m, 6H), 1.05–1.30 (m, 4H), 1.47–1.52 (m, 2H),
2.14–2.19 (m, 1H), 2.90–2.96 (m, 1H), 4.09 (dd, J = 3.2 Hz,
J = 10.8 Hz, 1H), 4.20 (dd, J = 10.0 Hz, J = 12.8 Hz, 1H), 4.77 (dd,
J = 3.2 Hz, J = 13.2 Hz, 1H), 7.22–7.29 (m, 3H), 7.34–7.40 (m, 2H),
7.49–7.54(m, 2H), 7.59–7.64 (m, 1H), 8.01 ppm (d, J = 8.4 Hz, 2H).
13C NMR (100 MHz, CDCl3): d = 12.2, 13.4, 19.8, 28.3, 33.1, 37.6,
48.9, 50.9, 127.2, 128.1, 128.5, 128.9, 133.7, 138.9, 141.1,
204.3 ppm. HRMS (ESI) calcd for C22H27NNaO3 [M+Na]: 376.1883,
found 376.1886. HPLC analysis: Chiralcel AD-H, 2-propanol/hexane
(5:95), 0.5 mL/min, UV 254 nm; t(minor) = 31.1 min, t(major)
t(major) = 26.2 min; 93% ee. [
a
]
D
22.8 = ꢀ28.6 (c 1.0, CH2Cl2).
4.1.1.16.
(2S,3S)-1-(4-Chlorophenyl)-2-((R)-2-nitro-1-phenyl-
1H NMR (400 MHz,
ethyl)-3-phenylpentan-1-one 4p3o,p
.
CDCl3): d = 0.56 (t, J = 7.2 Hz, 3H), 1.36–1.50 (m, 2H), 2.89 (td,
J = 3.6 Hz, 10.4 Hz, 10.4 Hz, 1H), 3.56–3.61 (m, 1H), 4.03 (dd,
J = 4.8 Hz, J = 10.0 Hz, 1H), 4.86 (dd, J = 4.0 Hz, J = 13.6 Hz, 1H),
4.95–5.02 (m, 1H), 6.94 (d, J = 8.0 Hz, 2H), 7.10–7.15 (m, 3H),
7.19–7.23 (m, 4H), 7.28–7.32 (m, 1H), 7.35–7.40 ppm (m, 4H).
13C NMR (100 MHz, CDCl3): d = 12.1, 26.9, 43.9, 49.3, 56.2, 75.0,
127.2, 127.4, 127.9, 128.7, 129.1, 129.5, 136.9, 137.9, 139.8,
140.7, 202.8 ppm. HPLC analysis: Chiralcel AD-H, 2-propanol/hex-
ane (5:95), 1.0 mL/min, UV 254 nm; t(minor) = 12.4 min, t(major)
= 42.8 min; 97% ee. [
a
]
D
26.1 = ꢀ85.4 (c 1.0, CH2Cl2).
4.1.1.12. (2S,3S)-3-(4-Methoxyphenyl)-2-((R)-2-nitro-1-phenyl-
ethyl)-1-phenyl pentan-1-one 4l3o,p 1H NMR (400 MHz,
.
CDCl3): d = 0.56 (t, J = 7.6 Hz, 3H), 1.34–1.40 (m, 1H), 1.44–1.48
(m, 1H), 2.87 (td, J = 3.2 Hz, 10.8 Hz, 10.8 Hz, 1H), 3.57–3.62 (m,
1H), 3.82 (s, 3H), 4.04 (dd, J = 4.8 Hz, J = 10.4 Hz, 1H), 4.90 (dd,
J = 3.6 Hz, J = 13.6 Hz, 1H), 4.99–5.05 (m, 1H), 6.91–6.95 (m, 4H),
7.10, (m, 3H), 7.16 (d, J = 8.8 Hz, 2H), 7.23 (d, J = 15.6, 2H), 7.40–
7.46 ppm (m, 3H). 13C NMR (100 MHz, CDCl3): d = 12.1, 27.2,
44.0, 48.7, 55.2, 56.3, 75.2, 114.4, 127.3, 127.6, 128.1, 128.3,
128.8, 128.9, 132.7, 133.2, 158.6, 204.2 ppm. HPLC analysis: Chiral-
cel AD-H, 2-propanol/hexane (5:95), 1.0 mL/min, UV 254 nm;
= 16.9 min; 95% ee. [
a]
22.8 = ꢀ29.8 (c 1.0, CH2Cl2).
D
4.1.1.17. (2S,3S)-2-((R)-1-(4-Bromophenyl)-2-nitroethyl)-3-(4-
methoxyphenyl)-1-phenylpentan-1-one 4q3o 1H NMR
.
(400 MHz, CDCl3): d = 0.55 (t, J = 7.2 Hz, 3H), 1.35–1.49 (m, 2H),
2.85 (td, J = 3.2 Hz, 10.4 Hz, 10.4 Hz, 1H), 3.53–3.57 (m, 1H), 3.82
(s, 3H), 4.03 (dd, J = 5.6 Hz, J = 10.4 Hz, 1H), 4.89 (dd, J = 4.0 Hz,
J = 13.6 Hz, 1H), 4.93–4.99 (m, 1H), 6.81 (d, J = 8.4 Hz, 2H), 6.91
(d, J = 8.8 Hz, 2H), 7.14 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H),